Lymphocele or Seroma After Modified Radical Mastectomy for Breast Cancer: Systematic Review and Meta-analysis.
Adrien Crestani, Katia Mahiou, Marie-Lucile Bodet, Alice Roosen, Bonneau Claire, Rouzier Roman
Abstract
Open-access reader
Adrien Crestani, Katia Mahiou, Marie-Lucile Bodet, Alice Roosen, Bonneau Claire, Rouzier Roman
Abstract
Open-access reader
Abstract Seroma or lymphocele remains the most common complication after mastectomy and lymphadenectomy for breast cancer. Many different techniques are available to prevent this complication. We searched MEDLINE, clinicaltrials.gov, Cochrane Library, and Web of Science databases for publications addressing the issue of prevention of lymphocele or seroma after mastectomy and axillary lymphadenectomy. Quality was assessed using a standardised tool. Incidence of seroma or lymphocele were collected. Fifteen randomized controlled trials including a total of 1,766 patients undergoing radical mastectomy and axillary lymphadenectomy for breast cancer were retrieved. The incidence of lymphocele or seroma in the study population was 24.2% (411/1698): 25.2% (232/920) in the test groups and 23.0% (179/778) in the control groups. Neither modification of surgical technique (RR= 0.86; 95%CI [0.72, 1.03]) nor application of a medical treatment (RR= 0.96; 95%CI [0.72, 1.29]) was effective in preventing lymphocele. On the contrary, decreasing the drainage time increased the risk of lymphocele (RR= 1.88; 95%CI [1.43, 2.48). To conclude, despite the heterogeneity of study designs, drainage appears to be the most effective technique.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Abstract Seroma or lymphocele remains the most common complication after mastectomy and lymphadenectomy for breast cancer. Many different techniques are available to prevent this complication. We searched MEDLINE, clinicaltrials.gov, Cochrane Library, and Web of Science databases for publications addressing the issue of prevention of lymphocele or seroma after mastectomy and axillary lymphadenectomy. Quality was assessed using a standardised tool. Incidence of seroma or lymphocele were collected. Fifteen randomized controlled trials including a total of 1,766 patients undergoing radical mastectomy and axillary lymphadenectomy for breast cancer were retrieved. The incidence of lymphocele or seroma in the study population was 24.2% (411/1698): 25.2% (232/920) in the test groups and 23.0% (179/778) in the control groups. Neither modification of surgical technique (RR= 0.86; 95%CI [0.72, 1.03]) nor application of a medical treatment (RR= 0.96; 95%CI [0.72, 1.29]) was effective in preventing lymphocele. On the contrary, decreasing the drainage time increased the risk of lymphocele (RR= 1.88; 95%CI [1.43, 2.48). To conclude, despite the heterogeneity of study designs, drainage appears to be the most effective technique.
Key concepts: Lymphocele, Seroma, Medicine, Mastectomy, Breast cancer, Lymphadenectomy, Cochrane Library, Surgery